REPORT ID 6231

United States Intrauterine Devices Market Report 2017

Publish Date
25-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the United States Intrauterine Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Intrauterine Devices in these regions, from 2012 to 2022 (forecast).

United States Intrauterine Devices market competition by top manufacturers/players, with Intrauterine Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer
    Merck
    Teva Pharmaceutical
    Allergan
    HRA Pharma
    Eurogine
    Yantai JiShengYaoXie
    TianYi
    SMB Corporation
    Shenyang Liren
    H & J Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hormonal IUD
    Copper IUD
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Age 20-24
    Age 25-34
    Age 35-44
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Intrauterine Devices Market Report 2017
1 Intrauterine Devices Overview
    1.1 Product Overview and Scope of Intrauterine Devices
    1.2 Classification of Intrauterine Devices by Product Category
        1.2.1 United States Intrauterine Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Intrauterine Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Hormonal IUD
        1.2.4 Copper IUD
    1.3 United States Intrauterine Devices Market by Application/End Users
        1.3.1 United States Intrauterine Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Age 20-24
        1.3.3 Age 25-34
        1.3.4 Age 35-44
        1.3.5 Other
    1.4 United States Intrauterine Devices Market by Region
        1.4.1 United States Intrauterine Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Intrauterine Devices Status and Prospect (2012-2022)
        1.4.3 Southwest Intrauterine Devices Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Intrauterine Devices Status and Prospect (2012-2022)
        1.4.5 New England Intrauterine Devices Status and Prospect (2012-2022)
        1.4.6 The South Intrauterine Devices Status and Prospect (2012-2022)
        1.4.7 The Midwest Intrauterine Devices Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Intrauterine Devices (2012-2022)
        1.5.1 United States Intrauterine Devices Sales and Growth Rate (2012-2022)
        1.5.2 United States Intrauterine Devices Revenue and Growth Rate (2012-2022)

2 United States Intrauterine Devices Market Competition by Players/Suppliers
    2.1 United States Intrauterine Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Intrauterine Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Intrauterine Devices Average Price by Players/Suppliers (2012-2017)
    2.4 United States Intrauterine Devices Market Competitive Situation and Trends
        2.4.1 United States Intrauterine Devices Market Concentration Rate
        2.4.2 United States Intrauterine Devices Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Intrauterine Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Intrauterine Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Intrauterine Devices Sales and Market Share by Region (2012-2017)
    3.2 United States Intrauterine Devices Revenue and Market Share by Region (2012-2017)
    3.3 United States Intrauterine Devices Price by Region (2012-2017)

4 United States Intrauterine Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Intrauterine Devices Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Intrauterine Devices Revenue and Market Share by Type (2012-2017)
    4.3 United States Intrauterine Devices Price by Type (2012-2017)
    4.4 United States Intrauterine Devices Sales Growth Rate by Type (2012-2017)

5 United States Intrauterine Devices Sales (Volume) by Application (2012-2017)
    5.1 United States Intrauterine Devices Sales and Market Share by Application (2012-2017)
    5.2 United States Intrauterine Devices Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Intrauterine Devices Players/Suppliers Profiles and Sales Data
    6.1 Bayer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Intrauterine Devices Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.2 Intrauterine Devices Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teva Pharmaceutical
        6.3.2 Intrauterine Devices Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teva Pharmaceutical Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Allergan
        6.4.2 Intrauterine Devices Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Allergan Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 HRA Pharma
        6.5.2 Intrauterine Devices Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 HRA Pharma Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Eurogine
        6.6.2 Intrauterine Devices Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Eurogine Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Yantai JiShengYaoXie
        6.7.2 Intrauterine Devices Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Yantai JiShengYaoXie Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 TianYi
        6.8.2 Intrauterine Devices Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 TianYi Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 SMB Corporation
        6.9.2 Intrauterine Devices Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 SMB Corporation Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Shenyang Liren
        6.10.2 Intrauterine Devices Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Shenyang Liren Intrauterine Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 H & J Medical

7 Intrauterine Devices Manufacturing Cost Analysis
    7.1 Intrauterine Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Intrauterine Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Intrauterine Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Intrauterine Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Intrauterine Devices Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Intrauterine Devices Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Intrauterine Devices Sales Volume Forecast by Type (2017-2022)
    11.3 United States Intrauterine Devices Sales Volume Forecast by Application (2017-2022)
    11.4 United States Intrauterine Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer